HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
IPSC
Century Therapeutics, Inc.
There isn't enough reported data to score IPSC yet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
IPSC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Unavailable | |
| Unavailable |
IPSC's revenue is currently healthy, but its profitability is weak. There isn't enough data to rate its cash flow and balance sheet.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
IPSC PE Valuation
IPSC has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
IPSC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong decline | |
| -- | |
| Limited | |
| High |
Analysts expect IPSC's losses to shrink, with revenue declining.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
IPSC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.64 | -$0.34 |
| Q2 2026 | -$0.93 | -$0.66 |
| Q1 2026 | -$1.14 | -$0.87 |
| Q4 2025 | -$0.14 | +$1.47 |
| Q3 2025 | -$0.30 | +$1.53 |
| Q2 2025 | -$0.27 | +$1.74 |
| Q1 2025 | -$0.27 | +$1.92 |
| Q4 2024 | -$1.61 | +$0.66 |
IPSC has the edge over HIMS on earnings, with more consistent year-over-year improvement.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the stronger quarterly revenue trend. Revenue is up 49% for HIMS versus down 100% for IPSC.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
IPSC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2025 | $109.2M | +12668% |
| Q4 2024 | $4.2M | +1457% |
| Q3 2024 | $791K | +434% |
| Q2 2024 | $771K | +679% |
| Q1 2024 | $855K | -50% |
| Q4 2023 | $268K | -49% |
| Q3 2023 | $148K | -93% |
| Q2 2023 | $99K | -93% |
IPSC's revenue is growing: $0 last quarter, down 100% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2025 | 68% | +3730 points |
| Q4 2024 | -893% | +15436 points |
| Q3 2024 | -4398% | +19674 points |
| Q2 2024 | -4508% | +30924 points |
| Q1 2024 | -3662% | -1797 points |
| Q4 2023 | -16329% | -9936 points |
| Q3 2023 | -24072% | -22645 points |
| Q2 2023 | -35431% | -33186 points |
IPSC's operating margin was 68% last quarter, up 3730 points from the same quarter a year ago, near the top of its range since 2022.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over IPSC on cash generation, producing positive trailing cash flow while its opponent burns cash.
IPSC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$22.8M | +$3M |
| Q2 2026 | -$20.5M | +$7.4M |
| Q1 2026 | -$25.8M | +$9.3M |
| Q2 2025 | -$27.9M | -$312K |
| Q1 2025 | -$35.1M | -$4.3M |
| Q2 2024 | -$27.6M | -$3.8M |
| Q1 2024 | -$30.8M | +$3.4M |
| Q4 2023 | -$27.2M | +$2M |
IPSC has burned cash in almost every quarter: −$85M over the past year, against −$116M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over IPSC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
IPSC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +661K shares |
| 1 year | +139% | +120M shares |
| 3 years | +248% | +147M shares |
| 5 years | +277% | +152M shares |
| Available history | +394% | +165M shares |
IPSC has 206M diluted shares, up 139% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
IPSC Net Leverage
IPSC's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
IPSC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.8 | Neutral |
| Stochastic | 36.3 | Neutral |
IPSC's weekly RSI is 44 (neutral) and its Stochastic is 36 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
IPSC PE vs Healthcare Sector
IPSC has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
IPSC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.54 | 5.8% above |
| 20 week MA | $1.86 | 12% below |
| 50 week MA | $1.94 | 16% below |
| 100 week MA | $1.28 | 27% above |
| 200 week MA | $2.06 | 21% below |
IPSC has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
IPSC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $22.8 | $18.2 | -20% |
| 2022 | $18.2 | $5.67 | -69% |
| 2023 | $5.67 | $3.32 | -41% |
| 2024 | $3.32 | $1.04 | -69% |
| 2025 | $1.04 | $1.09 | +4.8% |
| 2026 YTD | $1.09 | $1.63 | +50% |
IPSC has the edge over HIMS on returns for 2026, with the stronger performance.